Darren Snellgrove
SVP, Chief Financial Officer · 1 filing · Latest: Jul 1, 2026
HALOZYME THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
SVP, Chief Financial Officer · 1 filing · Latest: Jul 1, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|